首站-论文投稿智能助手
典型文献
Efficacy and Safety of Bushen Huoxue Formula in Patients with Discogenic Low-Back Pain:A Double-Blind,Randomized,Placebo-Controlled Trial
文献摘要:
Objective:To assess the efficacy and safety of Bushen Huoxue Formula(BSHXF)for the treatment of discogenic low-back pain(DLBP).Methods:This was a parallel,double-blind,randomized,clinical trial performed between May 2019 and June 2020.Seventy patients were assigned by computerized random number table to the treatment group(lumbar traction and BSHXF,35 cases)or the control group(lumbar traction and placebo,35 cases).The patients received intervention for 3 weeks.Assessment was conducted before treatment and at week 1,2,3 during treatment.Primary outcome was the self-reported score of Oswestry Disability Index(ODI).Secondary outcomes included Visual Analog Scale(VAS),clinical efficacy rate by minimal clinically important difference(MCID)as well as lumbar tenderness,muscle tone and lumbar spine mobility.Adverse reactions were recorded.Follow-up was performed at 1 and 3 months after the end of treatment.Results:In the treatment group,ODI score was significantly decreased compared with baseline(P<0.05)and the control group at 2-and 3-week treatment.Similarly,VAS score decreased compared with the baseline(P<0.05)and was lower than that in the control group at 2-and 3-week treatment(P<0.05).The clinical efficacy rate of the treatment group was higher than that of the control group after treatment[32.35%(11/34)vs.3.13%(1/32),P<0.05).Moreover,the tenderness,and muscle tone,as well as the back extension and left flexion in lumbar spine mobility in the treatment group at 3-week treatment were significantly improved compared with the control group(P<0.05).Follow-up showed that at 1-month after treatment,the treatment group had better outcomes than the control group with regard to a total score of ODI and VAS scores,as well as clinical efficacy rate(all P<0.05).Moreover,VAS score was still significantly lower than the control group at 3-month follow-up(P<0.05).No adverse reactions were reported during the study.Conclusion:BSXHF combined with lumbar traction can significantly improve the clinical symptoms including pain intensity,functionality,muscle tone,and lumbar spine mobility in DLBP patients.
文献关键词:
作者姓名:
ZHAN Jia-wen;LI Kai-ming;ZHU Li-guo;WANG Shang-quan;FENG Min-shan;WEI Xu;YU Jie;TANG Bin;YIN Xun-lu;HAN Tao;ZHANG Ping;LI Ling-hui;CHEN Ming;SHAO Chen-chen
作者机构:
General Orthopedics Department,Wangjing Hospital,China Academy of Chinese Medical Sciences,Beijing 100102,China;Key Laboratory of Beijing of Traditional Chinese Medicine Bone Setting,Beijing 100102,China;Orthopedics Department,Xiyuan Hospital,China Academy of Chinese Medical Sciences,Beijing 100091,China;The Second Department of Spine,Wangjing Hospital,China Academy of Chinese Medical Sciences,Beijing 100102,China
引用格式:
[1]ZHAN Jia-wen;LI Kai-ming;ZHU Li-guo;WANG Shang-quan;FENG Min-shan;WEI Xu;YU Jie;TANG Bin;YIN Xun-lu;HAN Tao;ZHANG Ping;LI Ling-hui;CHEN Ming;SHAO Chen-chen-.Efficacy and Safety of Bushen Huoxue Formula in Patients with Discogenic Low-Back Pain:A Double-Blind,Randomized,Placebo-Controlled Trial)[J].中国结合医学杂志(英文版),2022(11):963-970
A类:
Bushen,Discogenic,BSHXF,BSXHF
B类:
Efficacy,Safety,Huoxue,Formula,Patients,Low,Back,Pain,Double,Blind,Randomized,Placebo,Controlled,Trial,Objective,To,assess,efficacy,safety,treatment,discogenic,back,pain,DLBP,Methods,This,was,parallel,double,blind,randomized,trial,performed,between,May,June,Seventy,patients,were,assigned,by,computerized,number,table,group,lumbar,traction,cases,control,placebo,received,intervention,weeks,Assessment,conducted,before,during,Primary,self,reported,Oswestry,Disability,Index,ODI,Secondary,outcomes,included,Visual,Analog,Scale,VAS,rate,minimal,clinically,important,difference,MCID,well,tenderness,muscle,tone,spine,mobility,Adverse,reactions,recorded,Follow,months,after,Results,significantly,decreased,compared,baseline,Similarly,lower,than,that,higher,Moreover,extension,left,flexion,improved,showed,had,better,regard,total,scores,still,follow,No,adverse,study,Conclusion,combined,symptoms,including,intensity,functionality
AB值:
0.434059
相似文献
A trial of arbidol hydrochloride in adults with COVID-19
Zhao Jingya;Zhang Jinnong;Jin Yang;Tang Zhouping;Hu Ke;Sun Hui;Shi Mengmeng;Yang Qingyuan;Gu Peiyu;Guo Hongrong;Li Qi;Zhang Haiying;Li Chenghong;Yang Ming;Xiong Nian;Dong Xuan;Xu Juanjuan;Lin Fan;Wang Tao;Yang Chao;Huang Bo;Zhang Jingyi;Chen Shi;He Qiong;Zhou Min;Qu Jieming-Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China;Institute of Respiratory Diseases, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China;Department of Emergency, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Respiratory and Critical Care Medicine, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China;Department of Respiratory and Critical Care Medicine, Renmin Hospital, Wuhan University, Wuhan, Hubei 430060, China;Department of Endocrinology, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Respiratory Medicine, Wuhan Bauhinia Hospital, Wuhan, Hubei 430062, China;Department of Respiratory Medicine, Guanggu Hospital District, The Third Hospital of Wuhan, Wuhan, Hubei 430074, China;Department of Respiratory and Critical Care Medicine, Puren Hospital, Wuhan University of Science and Technology, Wuhan, Hubei 430081, China;Department of Respiratory Medicine, The Third People’s Hospital of Hubei Province, Wuhan, Hubei 430030, China;Department of Respiratory Medicine, The Sixth General Hospital of Hubei Province, Wuhan, Hubei 430015, China;Tuberculosis Department of Chengdu Public Health Clinical Medical Center, Chengdu, Sichuan 610066, China;Department of Neurology, Wuhan Red Cross Hospital, Wuhan, Hubei 430015, China;Department of Tuberculosis, Jinyintan Hospital, Wuhan, Hubei 430048, China;Department of Cardiology, The Third People’s Hospital of Hubei Province, Wuhan, Hubei 430030, China
Dynamic changes of renal cortical blood perfusion before and after percutaneous transluminal renal artery stenting in patients with severe atherosclerotic renal artery stenosis
Ma Na;Li Yan;Wang Siyu;Li Mengpu;Li Yongjun;Ai Hu;Zhu Hui;Wang Yang;Guo Fajin;Ren Junhong-Department of Sonography, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Vascular Surgery, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Cardiology, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Nuclear Medicine, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Medical Research & Biometrics Center, National Center for Cardiovascular Diseases and Fuwai Hospital, CAMS and PUMC, Beijing 100037, China
Effect and safety of anaprazole in the treatment of duodenal ulcers: a randomized, rabeprazole-controlled, phase III non-inferiority study
Zhu Huiyun;Pan Xue;Zhang Li;Sun Hongxin;Fan Huizhen;Pan Zhongwei;Huang Caibin;Shi Zhenwang;Ding Jin;Wang Qi;Du Yiqi;Lyu Nonghua;Li Zhaoshen-Department of Gastroenterology, Changhai Hospital of Navy Military Medical University, Shanghai 200433, China;Drug Clinical Trial Institution, Changhai Hospital of Navy Military Medical University, Shanghai 200433, China;Department of Gastroenterology, Yichun People’s Hospital, Yichun, Jiangxi 336028, China;Department of Gastroenterology, Meihekou Central Hospital, Meihekou, Jilin 135099, China;Department of Gastroenterology, The First Affiliated Hospital of Gannan Medical College, Ganzhou, Jiangxi 341001, China;Department of Gastroenterology, Hefei Second People’s Hospital, Hefei, Anhui 230011, China;Department of Gastroenterology, Jinhua Central Hospital, Jinhua, Zhejiang 321099, China;Department of Gastroenterology, Anqing Municipal Hospital, Anqing, Anhui 246004, China;Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China
Wenshen Jianpi recipe(温肾健脾方)induced immune reconstruction and redistribution of natural killer cell subsets in immunological non-responders of human immunodeficiency virus/acquired immune deficiency syndrome:a randomized controlled trial
TAO Zhuang;WANG Jian;CHEN Xin;LI Yonghong;YAN Yuguang;ZHANG Ao;ZOU Wen;LIU Ying-Research Center of AIDS Treatment with Traditional Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;Institute of Basic Theory for Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;Department of Integrated Traditional Chinese and Wetern Medicine,Kunming Hospital of Traditional Chinese Medicine,Kunming 650000,China;Department of Infection,No.6 People's Hospital of Shenyang City,Shenyang 110006,China;University of Chinese Academy of SoCIal SCIences,Beijing,100102,China
Shugan Jieyu capsule(舒肝解郁胶囊)improve sleep and emotional disorder in coronavirus disease 2019 convalescence patients:a randomized,double-blind,placebo-controlled trial
AN Xuedong;ZHANG Qing;TAO Junxiu;LI Li;CHEN Yun;LI Kejian;HE Jing;LIU Ru;GUO Juan;ZHANG Jia;ZHU Hui;LIAN Fengmei;LI Xiaodong-Endocrinology,Guang'anmen Hospital of China Academy of Chinese Medical Sciences,Beijing 100053,China;Orthopedics,Hubei Provincial Hospital of Traditional Chinese Medicine,Affiliated Hospital of Hubei University of Chinese Medicine,Hubei Institute of Traditional Chinese Medicine,Wuhan 430000,China;Liver Disease branch,Hubei Provincial Hospital of Traditional Chinese Medicine,Affiliated Hospital of Hubei University of Chinese Medicine,Hubei Institute of Traditional Chinese Medicine,Wuhan 430000,China;Psychology Department,Hubei Provincial Hospital of TCM,Affiliated Hospital of Hubei University of Chinese Medicine,Hubei Institute of Traditional Chinese Medicine,Wuhan 430000,China;Clinical College of Traditional Chinese Medicine,Hubei University of Traditional Chinese Medicine,Wuhan 430061,China
The Correlation Between Decreased Ornithine Level and Alleviation of Rheumatoid Arthritis Patients Assessed by a Randomized,Placebo-Controlled,Double-Blind Clinical Trial of Sinomenine
Ying Shi;Hu-Dan Pan;Jian-Lin Wu;Qing-Hua Zou;Xin-Yi Xie;Hong-Gang Li;Hua Zhou;Xi-Qing Bian;Wen-Fei Leng;Can-Jian Wang;Ya-Feng Wang;Yong-Fei Fang;Liang Liu-Department of Rheumatology,The Southwest Hospital of Army Military Medical University,Chongqing 400038,China;State Key Laboratory of Dampness Syndrome Chinese Medicine,The Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510000,China;State Key Laboratory of Quality Research in Chinese Medicine&Macau Institute for Applied Research in Medicine and Health,Macau University of Science and Technology,Macao 999078,China;People's Hospital of Changshou Chongqing,Chongqing 401220,China;Traditional Chinese Medicine Hospital Dianjiang Chongqing,Chongqing 408300,China;Medical Management Center,World Federation of Chinese Medicine Societies,Beijing 100101,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。